Helpful Links
Navigate OHIO
Connect With Us
As ITDI evolves, we are committed to fostering inclusive and dynamic research initiatives. To reflect our growth and attract diverse talent, we are redefining the Bacterial Pathogenesis Initiative as Microbial Pathogenesis—encompassing Bacteriology, Virology, and Drug Discovery. This expansion strengthens our ability to address infectious diseases from multiple perspectives, advancing both research and global health solutions.
The Bacterial Pathogenesis initiative represents a group of researchers investigating various aspects of bacterial pathogenesis including but not limited to molecular mechanism underlying virulence genes expression, virulence associated-bacterial processes and host-pathogen interactions.
The mission of the Bacterial Pathogenesis initiative is to foster research in the broad field of bacterial pathogenesis, to promote collaboration within Ohio University as well as with colleagues in other institutions, to train undergraduate and graduate medical students.
With the expansion and evolution of the Edison Biotech Institute (EBI), we hope to further collaborate and partner with researchers in the Drug Discovery arena to address drug development against infectious diseases.
With the addition of Dr. Maryam Ahmed, as well as a future virology position slated for HCOM, we hope that the renewed focus of the institute to include Virology in a more formal capacity.
(740) 593–9381 | Building 21, The Ridges
Ohio University | Athens OH 45701 | 740.593.1000 ADA Compliance | © 2018 Ohio University . All rights reserved.